Expressional analysis of primary breast cancer tissue and breast cancer cell lines (i.e., MDA-MB-23l, MDAMB-453, BT549, SK-BR-3, and MCF-7) demonstrated down-regulation of GAS5 expression. The gene discussed is GAS5; the disease is breast carcinoma.